View of Effects of combination therapy with empagliflozin and metformin on interleukin-1β and interleukin-6 secretion in type 2 diabetes patients

Return to Article Details Effects of combination therapy with empagliflozin and metformin on interleukin-1β and interleukin-6 secretion in type 2 diabetes patients Download Download PDF